Allergy Therapeutics PLC Banner Image

Allergy Therapeutics PLC

  • Ticker AGY
    Exchange LSE More
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Allergy Therapeutics PLC Logo Image
  • 501-1000 Employees
  • Based in Worthing, England
Allergy Therapeutics plc engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Acarovac MPLMore, Venomil, Synbiotics, Penicillin Diagnostics, and Peanut. The company also develops allergy vaccines for grass, tree, and house dust mite, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
4.8 / 5.0 (74)

Allergy Therapeutics PLC reports have an aggregate usefulness score of 4.8 based on 74 reviews.

Allergy Therapeutics PLC

Most Recent Annual Report

Allergy Therapeutics PLC
MOST RECENT 2023 Annual Report

Older/Archived Annual Reports

Allergy Therapeutics PLC Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!